Angiochem
Westmount, Canada · Founded 2003 · $55.5M raised
- Headquarters
- Westmount
- Founded
- 2003
- Business Model
- B2B
- Website
- angiochem.com
- Total Funding
- $55.5M
- Last Round
- $42.0M Series BSep 2024
- Rounds
- 3
About
Biotech developing EPiC peptide compounds to cross the blood-brain barrier for treating brain diseases.
Summary
Angiochem is a Healthcare company based in Westmount, Canada, founded in 2003. It has raised $55.5M in total across 3 rounds, most recently a $42.0M Series B round in Sep 2024. Investors include BDC Venture Capital.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...